Prosecution Insights
Last updated: April 19, 2026

Teijin Pharma Limited

6 pending office actions

Portfolio Summary

6
Total Pending OAs
3
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18498680 MENTAL DISORDER DETERMINATION DEVICE, TERMINAL DEVICE, CLASSIFIER, MENTAL DISORDER DETERMINATION ASSISTANCE METHOD, AND RECORDING MEDIUM DOAN, HY KHANH 3791 Non-Final OA Oct 31, 2023
18277912 OXYGEN ENRICHMENT DEVICE, CONTROL METHOD AND CONTROL PROGRAM LAWRENCE JR, FRANK M 1776 Final Rejection Aug 18, 2023
18277885 OXYGEN ENRICHMENT DEVICE, CONTROL METHOD AND CONTROL PROGRAM LAWRENCE JR, FRANK M 1776 Final Rejection Aug 18, 2023
18266956 TRANSCRANIAL MAGNETIC STIMULATOR YANG, YI-SHAN 3798 Non-Final OA Jun 13, 2023
18038603 PHOTOTHERAPEUTIC APPARATUS EISEMAN, LYNSEY C 3796 Final Rejection May 24, 2023
18007606 ANTI-IGF-1 RECEPTOR HUMANIZED ANTIBODY ALLEN, MARIANNE P 1647 Non-Final OA Dec 01, 2022

Managing Teijin Pharma Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month